Park Square has placed Glenn Reicin as Chief Financial Officer at Eccogene.
{
Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammatory conditions, today announced the appointment of Glenn Reicin, MBA as Chief Financial Officer.
https://www.biospace.com/press-releases/eccogene-appoints-glenn-reicin-as-chief-financial-officer
unknownx500
More posts by Park Square Executive Search
Recent posts from Park Square Executive Search
